IQVIA Holdings | IQV - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Accenture USD 2.46B 511.02M 2025-12
Agilent USD 442M 1000K 2025-09
Bruker USD -72.6M 73.1M 2025-09
Cardinal Health USD 598M 214M 2025-09
Celltrion KRW 14.6B 180.89B 2025-06
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cigna USD 2.3B 274M 2025-09
Cognizant Technology Solutions USD 14.9B 14.06B 2025-09
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
CVS Health USD 1.35B 4.84B 2025-12
Danaher USD 1.08B 421M 2025-09
Dentsply International USD -230M 77M 2025-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Elevance Health USD 215M 1.19B 2025-12
Hologic USD 229.7M 2.3M 2025-12
Humana USD 527M 214M 2025-09
IBM USD 2.43B 167M 2025-09
Illumina USD 220M 86M 2025-09
Infosys INR 91.87B 90.71B 2025-12
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Laboratory Of America USD 337M 32.3M 2025-09
McKesson USD 1.4B 344M 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pharma Mar EUR 40.2M 44.28M 2025-12
Publicis EUR 549M 487M 2025-06
Qiagen NV USD 134.73M 7.91M 2025-09
Quest Diagnostics USD 336M 57M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Sartorius EUR 85M 14.1M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Tilray USD -39.96M 39.19M 2025-09
UnitedHealth USD 3.23B 1.16B 2025-09
Veeva Systems USD 436.85M 14.82M 2025-09
Veradigm USD 35.3M 13.95M 2022-09
Waters USD 170.12M 7.57M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 523.11M 659.54M 2025-06